Synthesis and conformational characterization of the epidermal growth factor-like domain of blood coagulation factor IX carrying xylosyl-glucose

Glycoconjugate Journal

Volumn 21, Issue 5, 2004, Pages 197-203

  Kitamura, Mayuko ^a   Hojo, Hironobu ^a   Nakahara, Yoshiaki ^a   Ishimizu, Takeshi ^b   Hase, Sumihiro ^b  

^a TOKAI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

CD spectrum; EGF like domain; glycopeptide; solid phase synthesis; unmasked carbohydrate

Indexed keywords

BLOOD CLOTTING FACTOR 9; EPIDERMAL GROWTH FACTOR; GLUCOSE; SERINE; UNCLASSIFIED DRUG; XYLOSYL GLUCOSE;

AMINO ACID ANALYSIS; ARTICLE; CIRCULAR DICHROISM; GLYCOSYLATION; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SOLID;

AMINO ACID SEQUENCE; AMINO ACIDS; CIRCULAR DICHROISM; DISACCHARIDES; DISULFIDES; EPIDERMAL GROWTH FACTOR; FACTOR IX; FLUORENES; GLYCOPEPTIDES; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 6344278686     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:GLYC.0000045092.37417.0f     Document Type: Article

References (23)

1. Harris RJ, Spellman MW, O-linked fucose and other posttranslational modifications unique to EGF modules, Glycobiology 3, 219-24 (1993).
2. Bruckner K, Perez L, Clausen H, Cohen S, Glycosyltransferase activity of Fringe modulates Notch-Delta interactions, Nature 406, 411-5 (2000).
3. Moloney DJ, Panin VM, Johnston SH, Chen J, Shao L, Wilson R, Wang Y, Stanley P, Irvine KD, Haltiwanger RS, Vogt TF, Fringe is a glycosyltransferase that modifies Notch, Nature 406, 369-75 (2000).
4. Hase S, Kawabata S, Nishimura H, Takeya H, Sueyoshi T, Miyata T, Iwanaga S, Takao T, Shimonishi Y, Ikenaka T, A new trisaccharide sugar chain linked to a serine residue in bovine blood coagulation factors VII and IX, J Biochem (Tokyo) 104, 867-8 (1988).
5. Bjoern S, Foster DC, Thim L, Wiberg FC, Christensen M, Komiyama Y, Pedersen AH, Kisiel W, Human plasma and recombinant factor VII, J Biol Chem 266, 11051-7 (1991).
6. Takano Y, Habiro M, Someya M, Hojo H, Nakahara Y, Preparation of core 2 type tetrasaccharide carrying decapeptide by benzyl protection-based solid-phase synthesis strategy, Tetrahedron Lett 43, 8395-9 (2002).
7. Hojo H, Haginoya E, Matsumoto Y Nakahara Y, Nabeshima K, Toole BP, Watanabe Y, The first synthesis of peptide thioester carrying N-linked core pentasaccharide through modified Fmoc thioester preparation: Synthesis of an N-glycosylated Ig domain of emmprin, Tetrahedron Lett 44, 2961-4 (2003).
8. Guo ZW, Nakahara Y, Nakahara Y, Ogawa T, Solid-phase synthesis of a glycosylated peptide fragment of the IL-8 receptor containing two vicinal oligosaccharide chains, Carbohydr Res 303, 373-7 (1997).
9. Otvos LJ, Urge L, Hollosi M, Wroblewski K, Graczk G, Fasman GD, Thurin J, Automated solid-phase synthesis of glycopeptides. Incorporation of unprotected mono- and disaccharide units of N-glycoprotein antennae into T cell epitopic peptides, Tetrahedron Lett 31, 5889-92 (1990).
10. Reimer KB, Meldal M, Kusumoto S, Fukase K, Bock K, Small-scale solid-phase O-glycopeptide synthesis of linear and cyclized hexapeptides from blood-clotting factor IX containing O-(α-D-Xyl-1-3-D-Xyl-1-3-β-D-Glc) -L-Ser, J Chem Soc, Perkin Trans 1, 925-32 (1993).
11. Seitz O, Wong C-H, Chemoenzymatic solution- and solid-phase synthesis of O-glycopeptides of the mucin domain of MAdCAM-1. A general route to O-LacNAc, O-sialyl-LacNAc, and O-sialyl-Lewis-X peptides, J Am Chem Soc 119, 8766-76 (1997).
12. Mizuno M. Haneda K, Iguchi R, Muramoto I, Kawakami T, Aimoto S, Yamamoto K, Inazu T, Synthesis of a glycopeptide containing oligosaccharides: Chemoenzymatic synthesis of a eel calcitonin analogues having natural N-linked oligosaccharides, J Am Chem Soc 121, 284-90 (1999).
13. Ichiyanagi T, Takatani M, Sakamoto K, Nakahara Y, Ito Y, Hojo H, Nakahara Y, Synthesis of mucin-type glycopeptide (β hCG 130-145) by on-resin fragment condensation of the glycopeptide segments carrying unmasked oligosaccharides, Tetrahedron Lett 43, 3297-300 (2002).
14. Gobbo M, Biondi L, Filira F, Gennaro R, Benincasa M, Scolaro B, Rocchi R, Antimicrobial peptides: Synthesis and antibacterial activity of linear and cyclic drosocin and apidaecin 1b analogues, J Med Chem 45, 4494-504 (2002).
15. Xue J, Guo Z, Efficient synthesis of complex glycopeptides based on unprotected oligosaccharides, J Org Chem 68, 2713-9 (2003).
16. Yamamoto N, Ohmori Y, Sakakibara T, Sasaki K, Juneja LR, Kajihara Y, Solid-phase syntheis of sialylglycopeptides through selective esterification of the silalic acid residues of an Asn-linked complex-type sialyloligsaccharide, Angew Chem Int Ed 42, 2537-40 (2003).
17. Takemura T, Hojo H, Nakahara Y, Ishimizu T, Hase S, Application of Fmoc-amino acid carrying an unmasked carbohydrate to the synthesis of the epidermal growth factor-like domain of bovine blood coagulation factor IX, Org Biomol Chem 2, 133-6 (2004).
18. Fukase K, Hase S, Ikenaka T, Kusumoto S, Synthesis of new serine-linked oligosaccharides in blood-clotting factors VII and IX and protein Z, Bull Chem Soc Jpn 65, 436-45 (1992).
19. Sugawara F, Nakayama H, Ogawa T, Stereoselective synthesis of 1-α-cellobiosyloxy-2(R)- and 2(S)-propanol, Carbohydr Res 108, C5-9 (1982).
20. King DS, Fields CG, Fields GB, A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis, Int J Peptide Protein Res 36, 255-66 (1990).
21. Taylor JM, Mitchell WM, Cohen S, Epidermal growth factor, J Biol Chem 247, 5928-34 (1972).
22. Holladay LA, Savage Jr. CR, Cohen S, Puett D, Conformation and unfolding of epidermal growth factor and derivatives, Biochemistry 15, 2624-33 (1976).
23. 2+-binding epidermal growth factor-like domain: Its role in protein-protein interactions, Cell 82, 131-41 (1995).